The dose your serum isn’t telling you. Your $80 serum might be doing almost nothing

Before we formulate anything, we ask a narrower question: what, specifically, is failing in this skin, and at what concentration does an ingredient actually correct it? Dehydration, barrier breakdown, structural decline — these aren’t vague categories to us. They’re mechanisms, and each one has a dose-response threshold below which nothing meaningful happens.

The dosing problem nobody talks about

Most formulas stop at 5–15% active concentration, enough to list on a label, not always enough to move the mechanism.

Ours run from 15% up to 50%, calibrated to the specific pathway we’re targeting. That’s a harder, more expensive way to formulate. It’s also the only way we’ve found to make “will this work” a question with a real answer instead of a marketing promise.

Synergy, not stacking

The second layer is synergy; actives that amplify each other rather than compete for the same receptor or degrade each other’s stability.

This is where we go looking outside the standard rotation of trend ingredients, into formulation traditions from Latin America, Africa, and the Middle East that have solved for these mechanisms for generations, often more elegantly than anything currently patented. We’re not sourcing these ingredients for a story. We’re sourcing them because, at the right dose, they outperform what’s already on the market.

FIRÈNE is the first result of that process — a multi-peptide firming concentrate built to address three biological drivers of skin aging at once: structural decline, barrier breakdown, and dehydration.

The structural layer combines several clinically studied, patented peptides with Kigelia Africana — a botanical with a longstanding tradition among African Tsonga women of the Zambezi Valley for skin firming, whose bioactive compounds (iridoids, flavonoids, phytosterols) are now studied and used in contemporary firming skincare; plus horsetail extract for its naturally occurring silica, and liposomal caffeine. The barrier layer uses ceramides, cholesterol, and biomimetic lipids. The hydration layer relies on humectants and nourishing botanical oils.

It’s designed specifically for skin affected by aging, hormonal change, and GLP-1-associated shifts, not a generalized “anti-aging” claim, but a specific biological profile.

In early testing with a small group of estheticians and clinical skincare buyers, this was one of the formulas testers most wanted to see launched. We’re not citing a clinical trial, this was a group of roughly a dozen people, not a study, but one tester named it the single product she’d buy “if it were available in the market today,” and rated it 5 out of 5 on both effectiveness and likelihood to repurchase. We test small and slow before we scale.